A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Sirolimus, LC/MS/MS
Test Code36712
CPT Codes
80195 <br><strong>This test is not available for New York patient testing. For New York patient testing use test code 13608.</strong>
Preferred Specimen
2 mL whole blood collected in an EDTA (lavender-top) tube
Patient Preparation
Collect specimen 1 hour prior to next dose (12 hour trough)
Minimum Volume
1 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Clotted specimen
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report Available: 1-2 days
Clinical Significance
Sirolimus is an immunosuppressant drug used to prevent organ graft rejection. Therapeutic drug monitoring is used to optimize dose and avoid toxicity. Peak concentrations are reached in 2 hours following oral administration. Elimination half-life in males is approximately 72 hours; in females approximately 61 hours.